Open-Label Pilot Study of Long-Acting Injectable Naltrexone Treatment for Cannabis Dependence

Trial Profile

Open-Label Pilot Study of Long-Acting Injectable Naltrexone Treatment for Cannabis Dependence

Completed
Phase of Trial: Phase I/II

Latest Information Update: 21 Sep 2017

At a glance

  • Drugs Naltrexone (Primary)
  • Indications Drug dependence
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 17 May 2016 Status changed from recruiting to completed.
    • 31 Aug 2015 Planned End Date changed from 1 Sep 2015 to 1 Feb 2016 as reported by ClinicalTrials.gov record.
    • 31 Aug 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Feb 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top